Skip to main content
. 2013 Nov 27;34(2):200–207. doi: 10.1038/jcbfm.2013.208

Table 1. Study characteristics.

Study Patients included in analyses (n) Patient characteristics QUADAS score Subgroups in studies and outcome definitions (if applicable)
Chai12 85 Non-selected SAH patients 6 Symptomatic vasospasm: Arterial vasospasm (DSA/CTA/TCD)+neurologic deficit Asymptomatic vasospasma: Only arterial segments demonstrating vasospasm (DSA/CTA/TCD), while patients do not have neurologicdeficit No vasospasma: no arterial vasospasm (DSA/CTA/TCD); with or without neurologic deficit due to other causes
Dankbaar6 85 Non-selected SAH patients 11 DCI: Clinical deterioration (↓ GCS of ⩾2 points lasting >2 hours or a new focal deficit), excluding rebleeding, hydrocephalus, edema, postoperative swelling, infection, and metabolic disturbance as the cause Non-DCI: Clinically stable
Hickmann14 29 Non-selected SAH patients 8 Delayed neurologic deterioration: An increase in the NIHSS score by ⩾1 point or a decrease in the GCS score ⩾1 point, which could not be accounted for by other factors such as bleeding, seizure, infection, edema, electrolyte- or acid-base disturbances No delayed neurologic deterioration
Kanazawa15 19 Non-selected SAH patients 5 Symptomatic vasospasm: neurologic deficits due to vasospasm (by DSA) No symptomatic vasospasm
Killeen16 57 Non-selected SAH patients 9 DCI: New neurologic deficit distinct from baseline deficit caused by a SAH or surgical intervention, excluding rebleeding, hemorrhage, hydrocephalus, infection, metabolic disturbance, and seizure as the cause and/or a new infarction on CT/MRI after day 4 Non-DCI: Patients with none of the criteria above
Lagares7 39 Non-selected SAH patients 8 DCI: Clinical deterioration attributable to vasospasm, excluding rebleeding, hydrocephalus or electrolyte abnormalities as the cause, or a new infarct on CT related to vasospasm (not visible on admission or immediate posttreatment scan), or both Non-DCI: Patients without clinical deterioration or patients with clinical deterioration owing to other causes and without a new infarct on CT
Lanterna13 41 Non-selected SAH patients 11 DCI: A deterioration (↓ GCS of ⩾2 points or a new focal deficit), excluding rebleeding, hydrocephalus, and metabolic disturbances as the cause, with or without an infarction on the CT scan Non-DCI: Clinical deterioration owing to other causes or clinically stable
Rijsdijk10 27 Non-selected SAH patients 11 Clinical deterioration from DCI: clinical deterioration (↓ in consciousness or new focal deficit) lasting ⩾2 hours, excluding rebleeding, hydrocephalus, infections, and metabolic disturbances as the cause, with or without hypodensity on CT Non-DCI-related deteriorationb: A decrease in GCS of ⩾2 points from hydrocephalus or other medical causes (metabolic disturbances, infection) Clinically stableb
Sanelli11 96 Non-selected SAH patients 9 DCI: Clinical deterioration (↓ GCS of ⩾2 points or focal neurologic impairment), that was not apparent immediately after aneurysm occlusion and was not attributed to other causes by clinical assessment, CT or MR imaging, and laboratory studies Non-DCI: Clinical deterioration owing to other causes or clinically stable
Sviri17 46 Patients with cerebral vasospasm after aSAH 8 Delayed ischemic deterioration: worsening of neurologic condition (↓ GCS of ⩾2 points or a new hemiplegia or hemiparesis or↓muscle scale of ⩾2 points in a previously hemiparetic patient) lasting >30 minutes, excluding rebleeding, hydrocephalus, postoperative complications and systemic complications as the cause No delayed ischemic deterioration
Van der Schaaf8 46 Non-selected SAH patients 11 DCI: persisting clinical deterioration (new focal deficit and/or decrease in consciousness), excluding rebleeding, hydrocephalus, infections, and metabolic disturbances as the cause, with or without hypodensity on follow-up CT Non-DCI: clinical deterioration owing to other causes or clinically stable

aSAH, aneurysmal subarachnoid hemorrhage; CTA, CT angiography; DCI, delayed cerebral ischemia; DSA, digital subtraction angiography; GCS, Glasgow Coma Scale; MRI, magnetic resonance imaging; n, number; NIHSS, National Institutes of Health Stroke Scale; QUADAS: quality assessment of diagnostic accuracy studies;9 SAH, subarachnoid hemorrhage; TCD: transcranial Doppler.

a

In the analyses, the subgroups of asymptomatic vasospasm and no vasospasm were pooled (as non-DCI).

b

In the analyses, the subgroups of non-DCI-related deterioration and clinically stable patients were pooled (as non-DCI).